
GE Vernova is quietly building embedded value with its long-term SMR investments.
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

GE Vernova is quietly building embedded value with its long-term SMR investments.

SCHG, VUG, and QQQ each take a different structural approach to large-cap growth, and those differences compound into a significant performance gap over ten years. One fund has a defensible claim as the best vehicle for the AI era, but the case involves real tradeoffs most investors overlook.

Oklo's next-gen nuclear technology could deliver massive long-term returns, but investors should know a few things before diving into the stock.

Oklo had a disastrous market debut. Investors who held on to their shares, however, have had the last laugh.

Both energy stocks are attracting significant attention, but one is clearly the better buy.
Forecasts are rising for how much money Big Tech will throw at the AI data center build-out this year. But money may not get the job done if chips, skilled labor, and power bottlenecks stand in the way.

Oklo's Groves reactor milestone adds real-world nuclear operating experience, but larger Aurora projects still face regulatory and execution hurdles.

Oklo's nuclear opportunity is expanding, but rising spending and execution risks cloud its path to recurring power revenues.

SpaceX is the largest space company, while Oklo is an early-stage energy company.

As AI fuels demand for power, these companies are well-positioned to meet the moment.

A nuclear energy company made a big breakthrough. Will it lead to bigger profits for these nuclear energy ETFs?

SMR's proposed TVA program could unlock licensing, engineering and equipment work tied to up to 6 GW of new nuclear capacity.

SMR's regulatory head start and $1.9B liquidity support commercialization, but its rich valuation raises the stakes for contract conversion.

OKLO's nuclear ambitions gained traction with first revenues and key project milestones, but rising costs and widening losses remain major hurdles.

Oklo Inc. has already achieved first criticality at its Groves low-power test reactor on private land in Texas and reported its first-ever quarterly sales of US$1.21 million, even as its quarterly net loss widened to US$48.54 million with a basic loss per share of US$0.28. This combination of technical progress and initial revenue, built on a greenfield site under the U.S. Department of Energy’s Reactor Pilot Program, is beginning to translate Oklo’s advanced reactor vision into real-world...

NuScale holds a regulatory edge no other SMR company can claim, yet its stock has shed nearly a third of its value in 2026 alone. Find out what specific catalysts would need to align before a return to $15 becomes a real conversation.

The sale sounds like a lot, but the CEO still has skin in the game with nearly 472,000 shares owned directly.

There's one thing you must know before you buy Oklo stock.

The company also revealed that its nuclear facility in Texas reached criticality.
Oklo just hit a nuclear milestone that took under a year to achieve, while AST SpaceMobile absorbed a nine-figure launch loss and kept building anyway. One bet runs on atoms, the other on orbits, and only one of them makes sense to own right now.
It's a bit of a speculative investment right now, but there are encouraging signs.
Oklo received a series of price target cuts from Wall Street analysts, even as retail sentiment on Stocktwits fell from ‘extremely bullish’ to ‘bullish’ over the past 24 hours.
Oklo just reported its first-ever quarterly revenue.
Uranium Energy and Oklo stand to benefit from powerful tailwinds behind the nuclear energy industry, but only one stock stands out as a better play right now.
OKLO's Q2 performance reflects rising project execution costs, emerging acquisition-driven revenues and increased spending as nuclear development accelerates.
SMR's regulatory progress, supplier network and $1.9B liquidity support its outlook despite weak revenues and execution risks.
Oklo Inc. (NYSE:OKLO) just proved it can build a nuclear reactor as fast as it promised. On August 6, the company announced its Groves Isotope Test Reactor in Lockhart, Texas, achieved first criticality, a controlled, self-sustaining nuclear chain reaction, less than a year after groundbreaking. It’s the first project under the US Department of Energy’s […]
Oklo (NYSE:OKLO) announced a broad refresh of its executive leadership team, adding new heads across Product, Staff, Legal, Engineering, and Accounting. The company highlighted experience from organizations including the U.S. Nuclear Regulatory Commission, National Grid, and Joby Aviation among the new appointees. The reshaped leadership group is intended to support Oklo as it moves from pilot milestones toward commercial isotope production and closer regulatory engagement. For readers...
Oklo (NYSE:OKLO) reported a year-to-date net loss of $81.6 million through the second quarter of 2026 while outlining progress across its power, fuel and isotope businesses, including first criticality at its Groves isotope facility in Texas and continued development of its Aurora powerhouse project
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.